Wang, Yuru https://orcid.org/0000-0001-5204-3617
Pajdzik, Kinga
Zhao, Yutao https://orcid.org/0000-0002-4496-1394
Ye, Chang https://orcid.org/0000-0003-0236-5671
Stone, Talbot https://orcid.org/0009-0000-7843-5678
Zhang, Li-Sheng https://orcid.org/0000-0003-1872-9978
Zhang, Wen https://orcid.org/0000-0001-8577-2613
Assari, Mahdi https://orcid.org/0009-0002-9247-4221
Zhao, Wenxin https://orcid.org/0000-0001-5261-5910
Sepich-Poore, Caraline https://orcid.org/0000-0002-1853-4647
Dai, Qing https://orcid.org/0000-0002-8578-1568
Wang, Ke
Luo, Minkui https://orcid.org/0000-0001-7409-7034
Pan, Tao https://orcid.org/0000-0003-1096-8405
He, Chuan https://orcid.org/0000-0003-4319-7424
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM131858 (M.L.).)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (RM1 HG008935(C.H.))
Article History
Received: 14 July 2023
Accepted: 26 February 2026
First Online: 23 March 2026
Competing interests
: C.H. is a scientific founder and a member of the scientific advisory board of Accent Therapeutics, Inc. C.H. is also a shareholder of Epican Genetech. The remaining authors declare no competing interests.